Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry of patients with acute pulmonary embolism

Official title: Pulmonary Embolism WArsaw REgistry

Run by Medical University of Warsaw · NCT03916302 · Data updated 2026-11-12

This study is collecting information from patients with acute pulmonary embolism to see how different treatments affect their recovery and to help improve care for future patients.

More Pulmonary Embolism trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorMedical University of Warsaw
Academic / other
Locations1 site (Warsaw)
StatusRecruiting
StartedJanuary 1, 2008
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedOctober 27, 2023
Trial IDNCT03916302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with objectively confirmed acute pulmonary embolism who can provide informed consent.

Probably not a fit

Patients who do not provide consent for participation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Pulmonary Embolism WArsaw REgistry (PE-aWARE) is an ongoing prospective observational study that collects extensive data on patients with confirmed acute pulmonary embolism (APE) at a single center. Since its initiation in January 2008, the registry aims to gather information on patient characteristics, management strategies, and outcomes to reduce mortality and complications associated with APE. Key endpoints include the occurrence of PE recurrences, bleeding complications, and mortality, which will help in developing predictive scores for better clinical management.

Why it matters

Potential benefit: If successful, this registry could significantly improve the management and outcomes of patients with acute pulmonary embolism.

How similar studies have gone: Other observational studies on pulmonary embolism have shown success in improving patient outcomes through data collection and analysis.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* objectively confirmed pulmonary embolism
* Informed consent for the participation in the study, according to the requirements of the ethics committee

Exclusion Criteria:

* lack of consent

Where it's running

  • Department of Internal Medicine & Cardiology with the Centre for Management of Venous Thromboembolic Disease, Medical University of Warsaw
    Warsaw, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.